Here in the Boston area, cancer researchers abound. But there is something of a crisis in the field. As a professor/friend of mine who runs a lab here in town tells me, research has identified a host of therapeutic targets, but “results from the clinic have not produced encouraging outcomes and, to date, there have been no reliable lasting responses to therapies against many malignancies.”It seems that cancer cells are proving better than researchers thought at evasion. They evolve, adapting to treatments and circumventing them. Out-of-the-box thinking, and funding, may be what’s necessary.
Professor Andrew W. Lo discusses his proposal to use financial engineering to spread risks among investors and provide financial incentives to develop successful cancer treatments. He explains how the cancer megafund works, and how investors can make good money in finding a cure for cancer.
With rising interest rates hurting bond prices, investors and financial advisers are scrambling for other options to provide stability to their portfolios. Some of them have turned to "alternative" funds, many of which claim to offer bond-like stability without exposure to interest-rate rises. Alternative funds use hedge-fund-like strategies to try to capture returns that aren't tied to broad markets. Some funds use options to limit their market exposure, for example, or place bets that certain stocks will drop in value. Professor Andrew Lo comments on the use of alternative funds.